Personalized SBRT in Early-Stage Peripheral NSCLC
Clinical trial NCT07167459 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07167459
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-04
- Primary completion
- 2029-03-01
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.